Surprise FDA rejection halts Sesen Bio’s launch in its tracks, putting newly hired sales team in limbonews2021-08-16T23:39:18+00:00August 16th, 2021|Fierce Pharma|
Buckle up, pharma. Your industry faces a ‘pivotal’ 45 days in D.C., analyst warnsnews2021-08-16T17:27:51+00:00August 16th, 2021|Fierce Pharma|
Recro Pharma takes manufacturing business ‘bi-coastal’ with $50M deal for CDMO Irisysnews2021-08-16T15:06:01+00:00August 16th, 2021|Fierce Pharma|
Novavax taps Sanofi, Supernus vets amid quest to get its COVID-19 vaccine over the FDA finish linenews2021-08-16T14:58:01+00:00August 16th, 2021|Fierce Pharma|
FibroGen’s longtime CFO hands baton to J&J veteran as high-profile roxadustat blowup cues a likely overhaulnews2021-08-16T14:56:11+00:00August 16th, 2021|Fierce Pharma|
Pfizer’s tick-borne encephalitis vaccine TicoVac passes FDA muster, allowing travelers and the military easier accessnews2021-08-16T13:55:24+00:00August 16th, 2021|Fierce Pharma|
After FibroGen’s FDA rejection in anemia, Akebia CEO aims to seize first-in-class opening with vadadustatnews2021-08-16T12:49:30+00:00August 16th, 2021|Fierce Pharma|
Eli Lilly’s Olympic run ends with enduring stories of Team USA athletes’ sport and health questsnews2021-08-16T12:04:36+00:00August 16th, 2021|Fierce Pharma|
Merck’s Welireg scores FDA nod in cancers spurred by rare disease—and its label is broader than expectednews2021-08-13T19:21:46+00:00August 13th, 2021|Fierce Pharma|
Ogilvy Health’s new PR practice chief talks pharma image and social trendsnews2021-08-13T15:43:26+00:00August 13th, 2021|Fierce Pharma|
